Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	55.70B +5.7%
Revenue (ttm)	18.38B -8.0%
Net Income	1.57B -37.0%
EPS	0.99 -36.9%
Shares Out	1.59B
PE Ratio	35.37
Forward PE	23.07
Dividend	0.59 (1.66%)
Ex-Dividend Date	May 11, 2026

Volume	17,784,978
Open	33.57
Previous Close	35.68
Day's Range	33.57 - 35.86
52-Week Range	28.14 - 41.72
Beta	-0.12
Analysts	Buy
Price Target	41.29 (+17.9%)
Earnings Date	Aug 18, 2026

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 20,127
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2025, SHE:002422's revenue was 18.51 billion, a decrease of -15.13% compared to the previous year's 21.81 billion. Earnings were 1.70 billion, a decrease of -42.03%.